CFO
Callan Family Office Portfolio holdings
AUM
$3.14B
1-Year Est. Return
23.75%
1 Year Est. Return
+23.75%
AUM
$3.17B
AUM Growth
+$1.84B
(+138%)
Holding
941
Top Buys
| 1 | +$85.7M | |
| 2 | +$83M | |
| 3 | +$51.4M | |
| 4 |
Apple
AAPL
|
+$50.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$37.9M |
Top Sells
| 1 | +$2.79M | |
| 2 | +$1.88M | |
| 3 | +$1.84M | |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
+$1.36M |
| 5 |
iShares S&P 500 Value ETF
IVE
|
+$1.35M |
Sector Composition
| 1 | Technology | 23.34% |
| 2 | Financials | 14.8% |
| 3 | Healthcare | 9.6% |
| 4 | Industrials | 7.93% |
| 5 | Communication Services | 7.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TE
926
T1 Energy Inc
TE
$1.78B
| $12.7K | ﹤0.01% |
+10,288
|
|
||
927
Pacific Biosciences
PACB
$806M
| $12.4K | ﹤0.01% |
+10,024
|
|
||
928
Sutro Biopharma
STRO
$139M
| $11.5K | ﹤0.01% |
+1,618
|
|
||
929
FiscalNote
NOTE
$25.6M
| $10.8K | ﹤0.01% |
+1,677
|
|
||
930
ALX Oncology
ALXO
$79.7M
| $8.21K | ﹤0.01% |
+19,778
|
|
||
931
Opendoor
OPEN
$6.12B
| $6.3K | ﹤0.01% |
+12,217
|
|
||
932
Cabaletta Bio
CABA
$283M
| – | – |
-41,599
|
|
||
933
Criteo
CRTO
$1.02B
| – | – |
-7,347
|
|
||
|
DFS
934
DELISTED
Discover Financial Services
DFS
| – | – |
-16,316
|
|
||
935
Fate Therapeutics
FATE
$144M
| – | – |
-82,024
|
|
||
936
Hudbay
HBM
$9.55B
| – | – |
-53,883
|
|
||
937
iShares Russell 2000 Growth ETF
IWO
$14.4B
| – | – |
-843
|
|
||
938
RAPT Therapeutics
RAPT
$1.67B
| – | – |
-11,166
|
|
||
|
TGB
939
Taseko Mines
TGB
$2.6B
| – | – |
-54,528
|
|
||
940
Vanguard Small-Cap ETF
VB
$74.3B
| – | – |
-1,247
|
|
||
|
X
941
DELISTED
US Steel
X
| – | – |
-6,165
|
|